Resources for Food and Drug Administration (FDA)

FDA Approves New Test That Can Help Identify Heart Transplant Rejection

www.allheadlinenews.com

The U.S. Food and Drug Administration (FDA) on Wednesday allowed XDx Inc. to sell a test for heart-transplant patients. The drug will save the transplant patients from repeated biopsies to check if their bodies are rejecting the new organ.

Currently, transplant patients have to get tissue samples from the heart checked to look for signs if their body is rejecting the organ. Such procedures can be hard to perform and risky for the patient. The new non-invasive test will save them from this ordeal.The test was used by some laboratories previously but XDx officials said the FDA's approval will make it widely available to doctors.

View the Resource

Share or bookmarklet this web page at: